5334-27-0 Usage
Chemical classification
heterocyclic compound
Derived from a pyrazolo-pyrimidinone, containing a pyrazole and pyrimidinone rings.
Structure
sulfur-containing
A sulfur atom attached to the 6th carbon of the pyrazole ring.
Structure
methyl-substituted
A methyl group attached to the 1st carbon.
Biological activities
antiviral
Exhibits antiviral properties, making it a potential candidate for treating viral infections.
Biological activities
anticancer
Shows anticancer properties, which could lead to the development of new cancer treatments.
Pharmaceutical importance
potential lead compound
Its structure and functional groups make it a promising candidate for the development of novel drugs.
Further research needed
therapeutic potential
More studies are required to fully understand and harness its potential as a therapeutic agent.
Check Digit Verification of cas no
The CAS Registry Mumber 5334-27-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,3,3 and 4 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 5334-27:
(6*5)+(5*3)+(4*3)+(3*4)+(2*2)+(1*7)=80
80 % 10 = 0
So 5334-27-0 is a valid CAS Registry Number.
5334-27-0Relevant articles and documents
THERAPEUTICALLY ACTIVE PYRAZOLO-PYRIMIDINE DERIVATIVES
-
Page/Page column 61, (2014/07/08)
A series of pyrazolo[3,4-d]pyrimidine derivatives that are substituted at the 4- position by a diaza monocyclic, bridged bicyclic or spirocyclic moiety, are beneficial in the treatment and/or prevention of various human ailments, including inflammatory, autoimmune and oncological disorders; viral diseasesand malaria; and organ and cell transplant rejection.
